{"member_organisations": "", "identification_number": "294359117093-66", "fields_of_interest": "Economy, finance and the euro, Competition, Consumers, Employment and Social Affairs, Single market, Research and innovation, Public Health, Digital economy and society", "head_office_address": "All\u00e9e de la Recherche 60", "full_time_equivalent_fte": "0,75", "person_with_legal_responsibility": "Jean-Christophe Tellier", "inter_groups": "", "financial_year_start_date": "01/01/2017", "grants": "121223", "head_office_country": "Belgium", "eu_initiatives": "Engage governments and policymakers worldwide on issues important to UCB to: \n\u2022 Ensure patients have access to medicines they need \n\u2022 Provide coverage and reimbursement that reward innovation \n\u2022 Introduce sound, science-based regulation \n\u2022 Enable biotechnology research and development (R&D)", "organisation_name": "UCB", "belgium_office_post_code": "", "number_of_persons_involved": "2", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Companies & groups", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "24/04/2015", "website_address": "http://www.ucb.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Brussels", "membership": "EFPIA = European Federation of Pharmaceutical Industries and Associations \n(http://efpia.eu/) \n \nEBE = European Biopharmaceuticals Entreprises (http://www.ebe-biopharma.eu/)", "head_office_post_code": "1070", "goals__remit": "UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology and neurology. With approximately 7,500 people operating in 40 countries, the company generated revenue of \u20ac 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news", "industry_forums": "", "head_office_phone": "(+32)2 559 9999", "level_of_interest": "global", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "200000-299999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Public Limited Company", "person_in_charge_of_eu_relations": "Xavier Hormaechea", "customers": "", "belgium_office_post_box": "", "position": "Public Affairs Lead EU"}